documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
26 rows where docket_id = "FDA-2016-D-4308" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 26
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2016-D-4308-0032 | FDA | None FDA-2016-D-4308 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals | Notice | Notice of Approval | 2019-02-11T05:00:00Z | 2019 | 2 | 2019-02-11T05:00:00Z | 2019-02-11T12:59:41Z | 2019-01812 | 0 | 0 | 0900006483a5e832 | |
| FDA-2016-D-4308-0026 | FDA | None FDA-2016-D-4308 | 04 Reference 3 Compliance Program Guidance Manual Chapter 42 Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:36:48Z | 0 | 0 | 09000064839beb23 | |||
| FDA-2016-D-4308-0023 | FDA | None FDA-2016-D-4308 | 01 RBC Antigen_Reference List | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:34:03Z | 0 | 0 | 09000064839beb20 | |||
| FDA-2016-D-4308-0022 | FDA | None FDA-2016-D-4308 | Labeling of Red Blood Cell Units with Historical Antigen Typing Results; Guidance for Industry | Other | Guidance | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T05:00:00Z | 2024-11-12T22:52:35Z | 1 | 0 | 09000064839beb1e | ||
| FDA-2016-D-4308-0021 | FDA | None FDA-2016-D-4308 | Labeling of Red Blood Cell Units With Historical Antigen Typing Results; Guidance for Industry; Availability | Notice | Notice of Availability | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T05:00:00Z | 2018-12-21T14:24:57Z | 2018-27654 | 0 | 0 | 09000064839be0a5 | |
| FDA-2016-D-4308-0028 | FDA | None FDA-2016-D-4308 | 06 Reference 5 AABB Standards for Blood Banks and Transfusion Services 30th edition | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:38:11Z | 0 | 0 | 09000064839beb25 | |||
| FDA-2016-D-4308-0029 | FDA | None FDA-2016-D-4308 | 07 Reference 6 FDA Guidance for Industry Computer Crossmatch Computerized Analysis of the Compatibility between the Donors Cell Type and the Recipients Serum or Plasma Type April 2011 | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:39:29Z | 0 | 0 | 09000064839be828 | |||
| FDA-2016-D-4308-0027 | FDA | None FDA-2016-D-4308 | 05 Reference 4 Blood Product Advisory Committee Meeting Transcripts_ Dec 4 2012 | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:37:26Z | 0 | 0 | 09000064839beb24 | |||
| FDA-2016-D-4308-0031 | FDA | None FDA-2016-D-4308 | 09 Reference 8 FDA Guidance for Industry Availability of FDAs e_Submitter Program for Regulatory Submissions from Licensed Blood Establishments August 2011 | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:40:39Z | 0 | 0 | 09000064839be82a | |||
| FDA-2016-D-4308-0025 | FDA | None FDA-2016-D-4308 | 03 Reference 2 Poole J Daniels G Blood group antibodies and their significance in transfusion medicine Transfus Med Rev 2007 21_58_71 | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:36:02Z | 0 | 0 | 09000064839beb22 | |||
| FDA-2016-D-4308-0024 | FDA | None FDA-2016-D-4308 | 02 Reference 1 Daniels G Reid ME Blood groups the past 50 years Transfusion 2010 Feb 50_2_281_9 | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:35:17Z | 0 | 0 | 09000064839beb21 | |||
| FDA-2016-D-4308-0030 | FDA | None FDA-2016-D-4308 | 08 Reference 7 FDA Guidance for Industry Submission of CMC and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture | Supporting & Related Material | Background Material | 2018-12-21T05:00:00Z | 2018 | 12 | 2018-12-21T14:40:04Z | 0 | 0 | 09000064839be829 | |||
| FDA-2016-D-4308-0020 | FDA | None FDA-2016-D-4308 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Draft Guidance for Industry: Labeling of Red Blood Cell Units With Historical Antigen Typing Results | Notice | 30 Day Proposed Information Collection | 2018-10-22T04:00:00Z | 2018 | 10 | 2018-10-22T04:00:00Z | 2018-11-22T04:59:59Z | 2018-10-22T18:26:51Z | 2018-22959 | 0 | 0 | 0900006483837d3f |
| FDA-2016-D-4308-0008 | FDA | None FDA-2016-D-4308 | Reference 5 Blood Product Advisory ommittee Meeting Transcripts_ Dec 4 2012 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:53Z | 0 | 0 | 0900006482446f1b | |||
| FDA-2016-D-4308-0011 | FDA | None FDA-2016-D-4308 | 09 Reference 8 FDA Guidance for Industry Computer Crossmatch Computerized Analysis of the Compatibility between the Donors Cell Type and the Recipients Serum or Plasma Type April 2011 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:14:06Z | 0 | 0 | 0900006482446f1e | |||
| FDA-2016-D-4308-0004 | FDA | None FDA-2016-D-4308 | Reference 1 Daniels G Reid ME Blood groups the past 50 years Transfusion 2010 Feb 50_2_281_9 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:38Z | 0 | 0 | 0900006482446e45 | |||
| FDA-2016-D-4308-0012 | FDA | None FDA-2016-D-4308 | 10 Reference 9 FDA Guidance for Industry For the Submission of Chemistry Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:14:09Z | 0 | 0 | 0900006482446f1f | |||
| FDA-2016-D-4308-0005 | FDA | None FDA-2016-D-4308 | Reference 2 Poole J Daniels G Blood group antibodies and their significance in transfusion medicine Transfus Med Rev 2007 21_58_71 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:41Z | 0 | 0 | 0900006482446f18 | |||
| FDA-2016-D-4308-0001 | FDA | None FDA-2016-D-4308 | Labeling of Red Blood Cell Units With Historical Antigen Typing Results; Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T05:00:00Z | 2017-01-03T14:44:35Z | 2016-31771 | 0 | 0 | 0900006482445ef6 | |
| FDA-2016-D-4308-0003 | FDA | None FDA-2016-D-4308 | RBC Antigen Reference List re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:34Z | 0 | 0 | 0900006482446e44 | |||
| FDA-2016-D-4308-0006 | FDA | None FDA-2016-D-4308 | Reference 3 Compliance Program Guidance Manual Chapter 42 Blood and Blood Components Inspection of Licensed and Unlicensed Blood Banks Brokers Reference Laboratories and Contractors 7342_001 dated Jun 1 16 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:44Z | 0 | 0 | 0900006482446f19 | |||
| FDA-2016-D-4308-0010 | FDA | None FDA-2016-D-4308 | Reference 7 FDA Guidance for Industry Biological Product Deviation Reporting for Blood and Plasma Establishments October 2006 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:14:03Z | 0 | 0 | 0900006482446f1d | |||
| FDA-2016-D-4308-0009 | FDA | None FDA-2016-D-4308 | Reference 6 AABB Standards for Blood Banks and Transfusion Services 30th edition re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:59Z | 0 | 0 | 0900006482446f1c | |||
| FDA-2016-D-4308-0002 | FDA | None FDA-2016-D-4308 | Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Other | Guidance | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T05:00:00Z | 2017-04-04T03:59:59Z | 2024-11-07T23:52:00Z | 1 | 0 | 0900006482446e42 | |
| FDA-2016-D-4308-0007 | FDA | None FDA-2016-D-4308 | Reference 4 AABB_FDA Liaison Meeting April 12 2012 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:13:50Z | 0 | 0 | 0900006482446f1a | |||
| FDA-2016-D-4308-0013 | FDA | None FDA-2016-D-4308 | Reference 10 FDA Guidance for Industry Availability of FDAs e_Submitter Program for Regulatory Submissions from Licensed Blood Establishments August 2011 re Labeling of Red Blood Cell Units with Historical Antigen Typing Results Draft Guidance for Industry | Supporting & Related Material | Background Material | 2017-01-03T05:00:00Z | 2017 | 1 | 2017-01-03T15:14:12Z | 0 | 0 | 0900006482446f20 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;